Implantable devices for chronic access and drug delivery to the central nervous system.

This is a review of implantable devices for chronic access and drug delivery to the central nervous system (CNS) via the cerebrospinal fluid, extracellular fluid, and vascular pathways. The current applications of such devices in the management of mycotic meningitis, meningeal leukemia and carcinomatosis, solid malignant tumors of the CNS, intractable cancer-associated pain, unresectable cystic tumors and in cytologic, pharmacologic, and experimental studies on the cerebrospinal fluid (CSF) are assessed. Specific attention is paid to the applications of the most commonly used device, a subcutaneous reservoir and pump (SRP), including its major uses and complications. A new system for local chemotherapy of malignant gliomas, the tumor cyst device (TCD), is also described.

[1]  F. Petito,et al.  Eosinophilic meningitis in Hodgkin's disease. Report of a case and review of the literature. , 1983, Archives of internal medicine.

[2]  R. Heimbecker Long-term indwelling brain cannula. , 1983, Journal of Neurosurgery.

[3]  W. Shapiro,et al.  Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis. , 1983, Cancer research.

[4]  W. Ensminger,et al.  Benefit from and tolerance to continuous intrathecal infusion of morphine for intractable cancer pain. , 1982, Journal of neurosurgery.

[5]  J. Connors Cure of Ommaya reservoir associated Staphylococcus epidermidis ventriculitis with a simple regimen of vancomycin and rifampin without reservoir removal. , 1982, Medical and pediatric oncology.

[6]  J. Marr,et al.  Sterilization of Ommaya reservoir by instillation of vancomycin. , 1981, The American journal of medicine.

[7]  A. Engquist,et al.  Csf and plasma morphine after epidural and intrathecal application. , 1981, Anesthesiology.

[8]  R. Ojemann,et al.  Cancer pain relieved by long-term epidural morphine with permanent indwelling systems for self-administration. , 1981, Journal of neurosurgery.

[9]  T. Yaksh,et al.  Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. , 1981, Mayo Clinic proceedings.

[10]  D. Norris,et al.  Focal encephalopathy following methotrexate therapy. Administration via a misplaced intraventricular catheter. , 1981, Archives of neurology.

[11]  R. Benjamin,et al.  Penetration of N-(phosphonacetyl)-L-aspartate into human central nervous system and intracerebral tumor. , 1980, Cancer research.

[12]  J. Ponsky,et al.  Expanded applications of Broviac catheter. , 1980, Archives of Surgery.

[13]  M. Corder,et al.  Monitoring central nervous system methotrexate levels via subcutaneous reservoir. Sources of errors in sampling and their avoidance. , 1980, Cancer clinical trials.

[14]  L. Pitts,et al.  Management of the unresectable cystic craniopharyngioma by aspiration through an Ommaya reservoir drainage system. , 1980, Journal of neurosurgery.

[15]  M. Leavens,et al.  Ommaya reservoir placement: technical note. , 1979, Neurosurgery.

[16]  John E. Thomas,et al.  Pain relief by intrathecally applied morphine in man. , 1979, Anesthesiology.

[17]  W. Bleyer,et al.  Intraventricular versus intralumbar methotrexate for central-nervous-system leukemia: prolonged remission with the Ommaya reservoir. , 1979, Medical and pediatric oncology.

[18]  J. Galicich,et al.  Use of the Ommaya reservoir in the prevention and treatment of CNS leukemia. , 1979, The American journal of pediatric hematology/oncology.

[19]  J. Firth,et al.  Subcutaneous cerebrospinal fluid reservoirs in patients with acute leukaemia. , 2009, Scandinavian journal of haematology.

[20]  A. Spence,et al.  The ommaya reservoir. Newly recognized complications and recommendations for insertion and use , 1978, Cancer.

[21]  R. Simon,et al.  "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. , 1978, Blood.

[22]  H. Hoffman,et al.  Long-term control of recurrent cyst of the conus medullaris. Case report. , 1977, Journal of Neurosurgery.

[23]  J. Yoshida,et al.  Symptomatic Rathke's cleft cyst. Morphological study with light and electron microscopy and tissue culture. , 1977, Journal of neurosurgery.

[24]  A. Ommaya,et al.  Intracerebral delayed hypersensitivity reactions in glioblastoma multiforme patients , 1977, Cancer.

[25]  A. Ommaya,et al.  Primate model for long-term study of intraventricularly or intrathecally administered drugs and intracranial pressure. , 1977, Science.

[26]  W. Shapiro,et al.  Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. , 1975, The New England journal of medicine.

[27]  J. Fried,et al.  Proliferative kinetics of central nervous system (CNS) leukemia , 1975, Cancer.

[28]  J. Graybill,et al.  Complications with the Ommaya reservoir in patients with granulomatous meningitis. , 1973, Journal of neurosurgery.

[29]  J. Posner Reservoirs for intraventricular chemotherapy. , 1973, The New England journal of medicine.

[30]  J. Bennett,et al.  A subcutaneous reservoir for intrathecal therapy of fungal meningitis. , 1973, The New England journal of medicine.

[31]  T. Vietti,et al.  Clinical investigations in the treatment of meningeal leukemia: radiation therapy regimens vs. conventional intrathecal methotrexate. , 1969, Blood.

[32]  J. T. Garner,et al.  A new approach to inoperable craniopharyngiomas. , 1969, American journal of surgery.

[33]  A. Ommaya,et al.  INTRATHECAL CHEMOTHERAPY OF GLIOMAS: RATIONALE AND CURRENT STATUS , 1969 .

[34]  A. Ommaya,et al.  Experience with the subcutaneous cerebrospinal-fluid reservoir. Preliminary report of 60 cases. , 1968, The New England journal of medicine.

[35]  A. Ommaya,et al.  Cerebrospinal fluid perfusion for central nervous system neoplasms , 1966, Neurology.

[36]  A. Ommaya,et al.  Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. , 1965, Journal of the American Medical Association (JAMA).

[37]  A. Ommaya Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. , 1963, Lancet.

[38]  C. Zubrod,et al.  Mechanisms of Drug Absorption and Excretion Passage of Drugs in and out of the Central Nervous System , 1962 .

[39]  B. Brodie,et al.  KINETICS OF PENETRATION OF DRUGS AND OTHER FOREIGN COMPOUNDS INTO CEREBROSPINAL FLUID AND BRAIN , 1959 .